Caladrius Biosciences, Inc. (CLBS): Price and Financial Metrics
CLBS Price/Volume Stats
Current price | $6.40 | 52-week high | $9.75 |
Prev. close | $0.51 | 52-week low | $0.38 |
Day low | $5.73 | Volume | 1,796,440 |
Day high | $9.75 | Avg. volume | 522,308 |
50-day MA | $0.52 | Dividend yield | N/A |
200-day MA | $0.65 | Market Cap | 387.49M |
CLBS Stock Price Chart Interactive Chart >
Caladrius Biosciences, Inc. (CLBS) Company Bio
Caladrius Biosciences, Inc., formerly NeoStem, Inc., through its subsidiary, PCT, LLC, a Caladrius Company (PCT), provides development and manufacturing services to the cell therapy industry (which includes cell-based gene therapy). PCT specializes in cell and cell-based gene therapies.
CLBS Price Returns
1-mo | N/A |
3-mo | N/A |
6-mo | N/A |
1-year | N/A |
3-year | -55.56% |
5-year | -84.43% |
YTD | N/A |
2023 | N/A |
2022 | 0.00% |
2021 | -41.15% |
2020 | -43.03% |
2019 | -29.49% |
Loading social stream, please wait...